CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,000 | -98.0% | 1,000 | -94.1% | 0.00% | – |
| Q3 2021 | $102,000 | +142.9% | 17,048 | +0.0% | 0.00% | – |
| Q1 2021 | $42,000 | – | 17,045 | +1704400.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | -80.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 5 | -100.0% | 0.00% | – |
| Q2 2019 | $35,000 | +191.7% | 36,378 | +334.5% | 0.00% | – |
| Q1 2019 | $12,000 | +300.0% | 8,372 | +162.8% | 0.00% | – |
| Q4 2018 | $3,000 | -97.5% | 3,186 | -84.0% | 0.00% | – |
| Q3 2018 | $122,000 | +74.3% | 19,904 | +205.6% | 0.00% | – |
| Q2 2018 | $70,000 | -14.6% | 6,514 | -14.9% | 0.00% | – |
| Q1 2018 | $82,000 | +241.7% | 7,655 | +125.2% | 0.00% | – |
| Q4 2017 | $24,000 | +500.0% | 3,399 | +609.6% | 0.00% | – |
| Q3 2017 | $4,000 | +300.0% | 479 | +178.5% | 0.00% | – |
| Q2 2017 | $1,000 | -66.7% | 172 | -56.5% | 0.00% | – |
| Q1 2017 | $3,000 | -90.9% | 395 | -89.6% | 0.00% | – |
| Q4 2016 | $33,000 | – | 3,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |